Search results
HanxBio announces the publication of a research paper in Scientific Reports on preclinical...
FOX 4 Kansas City· 3 days agoHanxBio today announced that it has published a research article titled "Narazaciclib, a novel...
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 15 hours agoThat could be why the first generation of radiopharmaceuticals were flops, Seth, the Actinium CEO,...
FDA grants breakthrough status for Kura Oncology's AML drug candicate By Investing.com
Investing.com· 4 days agoFood and Drug Administration (FDA) has awarded Breakthrough Therapy Designation to its drug...
Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
Zacks via Yahoo Finance· 7 days agoBio-Path (BPTH) gains 30% on encouraging developmental updates from the early-stage study of its...
Deverra Therapeutics Granted FDA Fast Track Designation for DVX101
Digital Journal· 1 day agoDesignation Validates Preliminary Data and Supports Accelerated Drug Development SEATTLE, WA / ACCESSWIRE / April 24, 2024 / Deverra Therapeutics, Inc., a clinical-stage biotechnology company ...
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
Morningstar· 4 days agoFood and Drug Administration (FDA) for the treatment of patients with relapsed/refractory (R/R) NPM1-mutant acute myeloid leukemia (AML ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 16 hours agoSAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will
Is the FDA Pausing More Cancer Trials? It's Hard to Tell
Medscape· 2 days agoIs the FDA Pressing Pause on More Cancer Trials? In October, the US Food and Drug Administration...
CAR-T Plus Stem-Cell Transplant Promising for CD7+ Blood Cancers
MedPage Today· 2 days agoA strategy of sequential CD7 chimeric antigen receptor (CAR) T-cell therapy and haploidentical...
Ava's Army: Salonia forever a part of Oceanside
Newsday· 5 days agoTributes were paid in word and deed and a moment of silence was observed before the national anthem as players, coaches and community gathered to...